Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Dipanjan Banchur

MYSTERIOUS: Is amgen stock outperforming the s p 500 - What They Never Told You

Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, is a renowned player in the biotechnology industry. Valued at $163.62 billion by market cap, the company uses technology and human genetic data to discover, develop, manufacture, and deliver innovative medicine. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and AMGN fits right into that category. For more than 40 years, AMGN has been one of the leading players in using living cells to make biological medicines. The company is advancing a broad and deep pipeline that builds on its existing portfolio of drugs to treat cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.